Sabatier, Pierre
Amar, Jacques
Montastruc, François
Rousseau, Vanessa
Chebane, Leila
Bouhanick, Béatrice
Montastruc, Jean-Louis http://orcid.org/0000-0001-6341-6001
Article History
Received: 26 April 2019
Accepted: 9 August 2019
First Online: 15 August 2019
Compliance with ethical standards
:
: JA is a co-founder, shareholder, and consultant of VAIOMER (ExternalRef removed), a biotech company which specializes in tissue and blood microbiota analyses. He is at the editorial board of “La revue des microbiotes,” a journal sponsored by PiLeJe Laboratories. He received consultancy fees or support to attend meetings or grants for research from almost all companies marketing antihypertensive drugs. BB received consultancy fees or supports to attend meeting from Astra-Zeneca, Bouchara-Recordati, Lilly, Novartis, Novo-Nordisk, Sanofi, Servier, Takeda, and MSD, but she had no competing interest concerning this article. The other authors have no competing interests.
: The opinions and conclusions in this study are not necessarily those of the various centers or of the WHO or ANSM (Agence Nationale de Sécurité du Médicament et des produits de santé, France).